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Abstract
Aims Depression is common in people with diabetes, and related to higher HbA1c levels. Depression, however, is a
heterogeneous construct that involves a variety of symptoms. As little is known about the associations of individual
depressive symptoms with HbA1c, we explored these associations in outpatients with diabetes.
Methods The study was conducted in three tertiary diabetes clinics in the Netherlands. At baseline, the presence of the
nine depressive symptoms that are listed in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition
was assessed with the nine-item Patient Health Questionnaire (PHQ-9). At baseline and after a 1-year follow-up, HbA1c
was derived from the medical charts.
Results A total of 288 out of 646 subjects with diabetes (45%) reported one or more depressive symptom(s). Depressed
mood (b = 0.11, P = 0.005), sleeping difficulties (b = 0.16, P < 0.001), appetite problems (b = 0.15, P < 0.001) and
suicidal ideation (b = 0.14, P = 0.001) were significantly related to higher baseline HbA1c values. Furthermore,
depressed mood (b = 0.09, P = 0.03) sleeping difficulties (b = 0.12, P = 0.004), appetite problems (b = 0.11, P = 0.01)
and psychomotor agitation/retardation (b = 0.09, P = 0.04) were significantly related to higher HbA1c values at 1-year
follow-up. Associations were more pronounced in Type 1 diabetes than in Type 2 diabetes. None of the depressive
symptoms were related to change in HbA1c over time, except suicidal ideation.
Conclusion In people with diabetes, several individual depressive symptoms were related to higher HbA1c levels. These
associations persisted over time. More research is needed to investigate potential mechanistic pathways.
Diabet. Med. 30, e115–e122 (2013)
Introduction
Depression is common in people with diabetes. A meta-
analysis showed that the odds of depression are almost
doubled in people with Type 2 diabetes compared with
controls [1]. Although a systematic review concluded that
data for Type 1 diabetes were insufficient to draw firm
conclusions [2], a more recent study showed that the
prevalence of depression was higher in Type 1 diabetes than
in controls [3]. Depression is related to adverse outcomes in
people with diabetes, including an increased risk for diabetes
complications and mortality [4,5]. Poor glycaemic control
might play a central, mediating role in these associations. A
meta-analysis, published in 2000, showed that depression is
related to higher HbA1c levels, with standardized effect sizes
in the small to medium range [6], and other studies have
shown that elevated levels of HbA1c are related to the
development of diabetes complications and mortality [7–9].
Several longitudinal and intervention studies could not
replicate an association between depression and HbA1c [10–
12]. The inconsistent findings regarding the relationship
between depression and HbA1c may be related to the
heterogeneous concept and diagnosis of depression. The
diagnosis of depression is based on the frequency and severity
of a set of various symptoms. According to the Diagnostic
and Statistical Manual, fourth edition (DSM-IV), a diagnosis
of a major depressive disorder requires the presence of a
minimum of five out of nine symptoms, including at least one
of the two core symptoms of depression (depressed mood
and diminished interest or pleasure in activities) to be present
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for at least 2 weeks. These symptoms should be accompanied
by others, such as sleeping problems, alterations in move-
ment and problems with concentration. Hence, persons with
depression may substantially differ in the depressive
symptoms they have. At present, little is known about the
association of individual symptoms of depression with
HbA1c. Knowledge of the specific associations between
individual depressive symptoms and HbA1c may identify
subsets of people with diabetes requiring specific therapeutic
interventions. In addition, it may guide research on aetiol-
ogy, as the various depressive symptoms might signify
different pathophysiological pathways.
The aim of the study is to explore the association of
individual symptoms of depression with HbA1c in a large
cohort of outpatients with diabetes. Previous studies indicated
that high levels of HbA1c are related to several indicators for
poor sleeping quality in diabetes and fatigue [13,14]. We
therefore hypothesized that a differential relationship exists
between depressive symptoms andHbA1c.We expected higher
correlations for somatic depressive symptoms, such as fatigue
and appetite problems, because these depressive symptoms
reflect symptoms of prolonged hyperglycaemia.
Methods
Recruitment
This study was a secondary analysis of data from a multi-
centre depression screening research project in the Nether-
lands, which aimed to test whether screening for depression
with subsequent feedback was related to a reduction in
depressive symptoms compared with screening without
feedback [15]. The study design has been described in more
detail elsewhere [15,16].
Briefly, a random sample of 2055 outpatients with diabetes
was drawn from patient registers of three tertiary diabetic
clinics in the Netherlands: (1) 1000 outpatients of the VU
University Medical Centre (Amsterdam), (2) 555 outpatients
of the Haaglanden Medical Centre (The Hague) and (5) 500
outpatients of the Radboud University Medical Centre (Nij-
megen). Patientswere eligible for the current study if theywere
aged  18 years andhad established diabetes (Type 1orType
2).Written consentwas obtained fromall participants, and the
studywas approved by the localmedical ethics committee. The
investigations were carried out in accordance with the prin-
ciples of the Declaration of Helsinki.
Measurements
Participants received questionnaire booklets by mail in two
phases. The first questionnaire booklet contained questions
on socio-demographic and lifestyle characteristics. The
second questionnaire booklet, which was sent to the partic-
ipants after having received the first questionnaire, captured
depressive symptoms. From the medical records of the
patients, the following data were obtained: type of diabetes,
duration of diabetes, treatment regimen, presence of micro-
vascular complications, presence of cardiovascular disease,
HbA1c values and blood pressure.
Depressive symptoms
The presence and severity of depressive symptoms were
assessed with the nine-item Patient Health Questionnaire
(PHQ-9) [17]. This self-report questionnaire includes the
nine symptoms of the DSM-IV criteria for a major depressive
disorder, i.e. (I) lack of interest, (II) depressed mood, (III)
sleeping difficulties, (IV) fatigue, (V) appetite problems, (VI)
feelings of worthlessness, (VII) concentration problems,
(VIII) psychomotor agitation/retardation and (IX) suicidal
ideation. We assessed the presence of each symptom
according to the scoring algorithm for the PHQ-9. Each
symptom was scored as present if endorsed ‘more than half
the time’ or ‘nearly all the time’. Symptom 9 (suicidal
ideation) was counted when the symptom was present at all.
In addition, we classified our participants into those with and
without elevated depressive symptoms using a PHQ-9 cut-off
of  10 [17].
HbA1c
The HbA1c values were extracted from patients’ medical
records. Assessments were standardized and conducted
within 3 months before completion of the PHQ-9. After
1 year, follow-up HbA1c values were once more collected.
Because HbA1c was expressed in%, we used the mathemat-
ical formula (10.93 9 HbA1c value in% – 23.5) to recode
the values in mmol/mol [18].
Statistical analysis
Only patients with complete data on depressive symptoms
and baseline HbA1c were included in the present analysis.
Nine cross-sectional linear regression models were con-
structed for each individual depressive symptom to assess
its association with HbA1c. In a stepwise approach, we
adjusted the nine linear regression models for the following
potential confounders: sex, age, education level, ethnicity,
insulin treatment, body mass index and smoking. We also
studied whether the presence of elevated depressive symp-
toms (PHQ-9 score  10) was related to HbA1c values in
linear regression analysis. In sensitivity analyses, we stratified
our analyses for type of diabetes. Furthermore, the linear
regression analyses were repeated with (1) the 1-year follow-
up values of HbA1c and (2) change in HbA1c from baseline to
1-year follow-up as outcomes. All analyses were conducted
in SPSS Statistics, version 17.0. As this study was aimed at
exploring associations, we made no adjustments for multiple
testing [19]; P-values < 0.05 were considered as statistically
significant.
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Results
Of the 2055 invited patients with diabetes, 966 (47%)
completed the first questionnaire, of whom 772 (80%)
completed and returned the second questionnaire that
captured depressive symptoms. A total of 646 participants
had complete data on both HbA1c values and PHQ–9.
Table 1 shows the baseline characteristics of the total
sample stratified by diabetes type. In our sample group
49% were female, the mean age was 53.3 ( 15.1) years,
57% had Type 2 diabetes and 91% were on insulin
treatment (Type 1 diabetes: 100%, Type 2 diabetes 84%).
Furthermore, 288 participants (45%) had one or more
depressive symptoms present on the PHQ-9. Symptoms
that were most often reported in the total sample were
fatigue, sleeping difficulties, problems with concentration
and appetite problems. Participants with Type 2 diabetes
reported more sleeping difficulties, problems with concen-
tration and appetite problems compared with participants
with Type 1 diabetes.
Overall, mean baseline HbA1c was 61  14 mmol/mol
(7.7  1.3%). For 552 out of 646 participants (85%), 1-year
follow-up HbA1c levels were available and amounted
62  14 mmol/mol (7.8%  1.3%). The Pearson correla-
tion between HbA1c values over time was high (r = 0.78,
P < 0.001). The HbA1c values did not differ for type of
diabetes.
Figure 1 shows the mean baseline and follow-up values of
HbA1c for the presence and absence of each symptom of the
PHQ-9. The presence of each symptom was related to higher
HbA1c levels, but the strength and statistical significance of
the relationship varied over symptoms.
Cross-sectional analyses
Univariable linear regression analyses showed a statistically
significant correlation between baseline HbA1c and the
symptoms depressed mood, sleeping difficulties, fatigue,
appetite problems, feelings of worthlessness and suicidal
ideation (Table 2). Although elevated depressive symptoms
(PHQ-9 score  10) were related to baseline HbA1c
(b = 0.12, P = 0.003), some of the individual symptoms
showed a stronger association (e.g. sleeping difficulties and
appetite problems). After adjustment for several potential
demographic, lifestyle and clinical confounders, the follow-
ing symptoms remained significantly related to higher base-
line HbA1c levels (Table 2): depressed mood, sleeping
difficulties, appetite problems and suicidal ideation. Report-
ing elevated depressive symptoms (PHQ-9 score  10) was
also positively associated with HbA1c (b = 0.10, P = 0.009),
but more weakly than some of the individual symptoms (e.g.
sleeping difficulties and appetite problems). For those with
Type 1 diabetes, the symptoms depressed mood, sleeping
difficulties, appetite problems, concentration problems, and
suicidal ideation were related to higher baseline HbA1c
levels, whereas for Type 2 diabetes a significant association
with baseline HbA1c was observed for sleeping difficulties,
appetite problems and suicidal ideation (Table 2).
Longitudinal analyses
Table 3 shows the relationship between each baseline
depressive symptom and the follow-up values of HbA1c.
Multivariable analyses showed that depressed mood, sleep-
ing difficulties, appetite problems and psychomotor agita-
tion/retardation were significantly correlated with HbA1c
levels after 1 year. For participants with Type 1 diabetes, the
symptoms sleeping difficulties, appetite problems, concen-
tration problems and psychomotor changes were related to
higher follow-up HbA1c levels, whereas for Type 2 diabetes
none of the symptoms were significantly related to follow-up
HbA1c levels. Furthermore, none of the depressed symptoms
were related to change in HbA1c from baseline to 1-year
follow-up in the total sample, except for the symptom
suicidal ideation (b = 0.12, P = 0.005, fully adjusted anal-
yses). Patients expressing suicidal ideation at baseline showed
a decline in HbA1c over time compared with those without
this symptom.
Discussion
In a large cohort of outpatients with diabetes from three
tertiary diabetes clinics, we observed that the presence of
several individual depressive symptoms (i.e. depressed mood,
sleeping problems, appetite problems and suicidal ideation)
was associated with higher concurrent HbA1c levels. The
baseline depressive symptoms depressed mood, sleeping
difficulties, and appetite problems were related to higher
HbA1c levels 1 year later. The reported associations were
more pronounced in people with Type 1 diabetes. Baseline
PHQ-9 symptoms, however, did not predict change in HbA1c
over time, except for a decline in HbA1c in patients who
expressed suicidal ideation at baseline.
A positive association between depression and HbA1c was
observed in a meta-analysis more than 10 years ago for both
Type 1 and Type 2 diabetes [6], but some recent longitudinal
and intervention studies could not confirm this [10–12]. One
of the reasons for the inconsistent results regarding the
relationship between depression and HbA1c might be
ascribed to the definition of the construct depression. In
many studies, depression is treated as a homogeneous
syndrome rather than a heterogeneous condition. In analogy
with initiatives in psychiatry and psychosomatic research on
the ‘deconstruction of depression’ [20,21], it may be impor-
tant to focus on the differential characteristics of depression,
such as different trajectories and symptoms and their
relationship with HbA1c. Furthermore, as the adverse asso-
ciation between depressive symptoms and HbA1c is not
restricted to elevated depression scores [22], the entire range
of depression scores may be of interest.
ª 2012 The Authors.
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We are aware of one previous study that investigated
depressive symptom profiles more closely in relation to
HbA1c. Nefs et al. [23] showed that anhedonia (loss of
interest or pleasure), but not depressed mood or anxiety, was
related to suboptimal glycaemic control (HbA1c values above
53 mmol/mol, 7%) in patients with Type 2 diabetes who
Table 1 Baseline characteristics of the sample (n = 646)
Total Type 1 diabetes Type 2 diabetes
n % n % n %
Female 329/646 49 158/277 57 170/365 47




183/646 28 45/277 16 138/365 38
Ethnic minority 66/646 10 8/277 3 58/365 16
Type 1 diabetes 277/642 43 277/277 100 0 0
Type 2 diabetes 365/642 57 0 0 365/365 100
Treatment of diabetes
Diet 93/644 14 20/277 7 73/363 20
Oral medication 199/644 31 12/277 4 187/363 52
Insulin 586/644 91 277/277 100 305/363 84
Severe hypoglycaemic episodes in the last 12 months 164/646 25 92/277 33 70/365 19
Complications (medical chart)
Cardiovascular disease 137/582 24 18/247 7 119/335 36
Retinopathy 195/590 33 103/254 41 92/336 27
Nephropathy 126/592 21 38/253 15 88/339 26
Neuropathy 137/587 23 45/250 18 92/337 27
Smoking
Never 297/640 46 136/274 50 159/362 44
Ex-smoker: quit > 1 year ago 191/640 30 64/274 23 126/362 35
Ex-smoker: quit 1 year ago 22/640 3 15/274 6 7/362 2
Current smoker 130/640 20 59/274 22 70/362 19
Alcohol
No 274/641 43 73/276 26 200/361 55
1–7 glasses/week 214/641 33 115/276 42 96/361 27
8–14 glasses/week 98/641 15 62/276 22 36/361 10
> 14 glasses/week 55/641 9 26/276 10 29/361 7
Depression hospitalization
in psychiatric hospital during life
21/643 3 9/277 3 12/362 3
Treated for depression
in the past
153/640 24 80/275 29 73/361 20
Prevalence of each
depressive symptom
PHQ 1: Lack of interest 92/646 14 33/277 12 59/365 16
PHQ 2: Depressed mood 54/646 8 22/277 8 32/365 9
PHQ 3: Sleeping difficulties 162/646 25 57/277 21 104/365 28
PHQ 4: Fatigue 174/646 27 65/277 23 108/365 30
PHQ 5: Appetite problems 101/646 16 33/277 12 68/365 19
PHQ 6: Worthlessness 76/646 12 29/277 10 47/365 17
PHQ 7: Concentration problems 107/646 17 33/277 12 73/365 20
PHQ 8: Psychomotor
agitation/retardation
62/646 10 21/277 8 41/365 11
PHQ 9: Suicidal ideation 71/646 11 23/277 8 48/365 13
n Mean (SD) n Mean (SD) n Mean (SD)
Age 640 53.3 (15.1) 273 43.9 (13.7) 363 60.5 (11.8)
Duration of diabetes (years) 546 17.5 (11.7) 253 22.1 (12.8) 293 13.6 (8.9)
Body mass index (kg/m2) 626 27.9 (6.0) 275 25.4 (4.1) 348 30.0 (6.6)
Systolic blood pressure (mmHg, medical chart) 427 136 (18) 180 132 (16) 247 138 (19)
Diastolic blood pressure (mmHg, medical chart) 427 76 (11) 180 75 (10) 247 76 (11)
HbA1c baseline
mmol/mol 646 61 (14) 277 62 (14) 365 61 (14)
% 646 7.7 277 7.8 (1.3) 365 7.7 (1.3)
n Median (IQR) n Median (IQR) n Median (IQR)
CES-D score 638 10 (5–18) 276 8 (4–16) 358 11 (5–20)
PHQ-9 score 646 4 (1–9) 277 3 (1–8) 365 4 (1–9)
CES-D, Centre of Epidemiologic Studies Depression; IQR, interquartile range; PHQ-9, Patient Health Questionnaire nine-item version. Type
of diabetes unknown, n = 4.
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were treated in primary care settings, and were generally in
good glycaemic control. In contrast, we found no significant
association between lack of interest and HbA1c in our
sample. Furthermore, we observed a significant association
between depressed mood and HbA1c only among people with
Type 1 diabetes and not for Type 2 diabetes.
Our study reports standardized beta-values, which
enables comparison of the relative importance of associa-
tions. All individual symptoms had correlations with
elevated HbA1c in the hypothesized direction, although the
strength of association for some depressive symptoms was
negligible. Moreover, the association of some individual
depressive symptoms with HbA1c was more pronounced
than that of moderate depression, as indicated by PHQ-9
scores  10.
Overall, we observed that sleeping problems were most
strongly related to higher HbA1c values. Sleeping problems
are more common in individuals with either Type 1 or Type
2 diabetes compared with those without diabetes [24,25].
Previous studies showed associations of poor glycaemic
control with adverse sleep characteristics in individuals with
Type 2 diabetes [13,14], but not in individuals with Type 1
diabetes [25]. It remains unclear whether sleeping problems
predict or might be a consequence of elevated HbA1c values,
or that one or more common denominators causes both sleep
problems and poor glycaemic control. For example, sleep
problems may also result from frequent nightly urination
owing to high glucose levels, or may be caused by obstructive
sleep apnoea, which is prevalent among individuals with
Type 2 diabetes. However, reduced duration of sleep has
been related to impaired glucoregulation and incident
diabetes in prospective studies [26], supporting the proposi-
tion of sleeping problems influencing glycaemic control in
Type 2 diabetes. Sleep disorders are related to alterations of
various biological systems (e.g. sympathetic nervous system,
hypothalamic–pituitary–adrenal axis, inflammation) which
are implicated in glucoregulation [27].
We further observed that appetite problems were related to
poor glycaemic control, in particular in participants with
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FIGURE 1 Mean HbA1c level in people with (closed bar) and without the symptom (tinted bar), for each of the PHQ-9 symptoms. *P < 0.05. To
convert HbA1c mmol/mol to%, the following formula can be applied: HbA1c in% = 0.0915 9 HbA1c in mmol/mol + 2.15%
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HbA1c values and vice versa. Alternatively, appetite prob-
lems might be a result of sleep problems. For example,
experimental and observational studies show that sleep loss
is related to an up-regulation of the appetite-stimulating
hormone ghrelin and down-regulation of the satiety hormone
leptin in persons without diabetes [28].
We further observed that two cognitive–affective symp-
toms of depression (depressed mood, and suicidal ideation)
were significantly related to HbA1c in the total sample.
Depressed mood and suicidal ideation may be indicators for
a more severe type of depression. They may be related to
HbA1c mainly because of poorer self-care aspects (e.g. taking
prescribed medications), although biological changes are also
possible. The relationship of suicidal ideation at baseline
with a subsequent decline in HbA1c was surprising. Possibly,
suicidal ideation is linked to concurrent levels of HbA1c
rather than future levels. The severity symptom may have
been reduced over time together with HbA1c, although we
lacked follow-up data of this symptom to verify this.
Some depressive symptoms (e.g. fatigue, appetite prob-
lems) may overlap with symptoms of prolonged hyperglyca-
emia. McDade et al. [29], however, showed that the structure
of depression and anxiety symptoms is similar across
individuals with diabetes and adults in the general commu-
nity without diabetes. Although the overlapping symptoms
of hyperglycaemia and depression may result from glycaemic
disturbances, they showed that these symptoms were, none-
theless, strongly associated with mood and distress, and
argued that overlapping symptoms should not immediately
be attributed to the diabetes disease process [29].
Because correlations between each symptom and HbA1c
were small, the symptoms will explain only a small part of
the variance in HbA1c. However, the mean difference in
HbA1c between patients with and patients without individual
depressive symptoms was up to 6 mmol/mol (0.5%), which
is considered a clinically relevant difference.
Strengths of the current study are the large sample size, the
use of longitudinal data for HbA1c, and the inclusion of a
mixed sample of people with Type 1 and Type 2 diabetes.
Furthermore, we used the items of PHQ-9, which corre-
sponds to the DSM-IV symptoms of major depression.
However, limitations of the study should also be acknowl-
edged. First, the PHQ-9 was validated for the construct
depression but not for the constructs of each single symptom
of depression. Second, the use of the PHQ-9 limited our
conclusions regarding the direction of the association as
Table 2 Standardized regression coefficients from nine separate linear regression analyses for the association of each Patient Health Questionnaire
(PHQ) item and baseline HbA1c
Model 1 Model 2 Model 3 Model 4
b P b P b P b P
Total sample (n = 614)
PHQ 1: Lack of interest 0.07 0.074 0.07 0.104 0.06 0.145 0.05 0.188
PHQ 2: Depressed mood 0.13 0.001 0.12 0.002 0.11 0.004 0.11 0.005
PHQ 3: Sleeping difficulties 0.17 < 0.001 0.17 < 0.001 0.17 < 0.001 0.16 < 0.001
PHQ 4: Fatigue 0.10 0.014 0.08 0.037 0.08 0.040 0.07 0.090
PHQ 5: Appetite problems 0.16 < 0.001 0.15 < 0.001 0.15 < 0.001 0.15 < 0.001
PHQ 6: Worthlessness 0.10 0.015 0.09 0.027 0.08 0.046 0.08 0.05
PHQ 7: Concentration problems 0.07 0.09 0.07 0.070 0.07 0.077 0.07 0.06
PHQ 8: Psychomotor changes 0.04 0.323 0.05 0.257 0.04 0.306 0.04 0.329
PHQ 9: Suicidal ideation 0.16 < 0.001 0.16 < 0.001 0.16 < 0.001 0.14 0.001
Type 1 diabetes (n = 268)
PHQ 1: Lack of interest 0.15 0.017 0.13 0.029 0.13 0.028 0.11 0.054
PHQ 2: Depressed mood 0.17 0.006 0.15 0.010 0.15 0.010 0.15 0.011
PHQ 3: Sleeping difficulties 0.22 < 0.001 0.21 < 0.001 0.22 < 0.001 0.17 0.004
PHQ 4: Fatigue 0.12 0.054 0.09 0.152 0.09 0.148 0.05 0.428
PHQ 5: Appetite problems 0.25 < 0.001 0.24 < 0.001 0.24 < 0.001 0.20 0.001
PHQ 6: Worthlessness 0.13 0.033 0.12 0.049 0.11 0.059 0.08 0.196
PHQ 7: Concentration problems 0.19 0.002 0.19 0.002 0.18 0.002 0.18 0.002
PHQ 8: Psychomotor changes 0.05 0.427 0.04 0.517 0.03 0.586 0.05 0.439
PHQ 9: Suicidal ideation 0.16 0.009 0.16 0.008 0.15 0.011 0.13 0.025
Type 2 diabetes (n = 343)
PHQ 1: Lack of interest 0.03 0.628 0.02 0.694 0.01 0.830 0.01 0.883
PHQ 2: Depressed mood 0.10 0.054 0.10 0.067 0.08 0.127 0.08 0.137
PHQ 3: Sleeping difficulties 0.15 0.006 0.15 0.007 0.14 0.007 0.14 0.010
PHQ 4: Fatigue 0.09 0.079 0.09 0.110 0.08 0.128 0.07 0.223
PHQ 5: Appetite problems 0.11 0.050 0.10 0.073 0.10 0.055 0.11 0.040
PHQ 6: Worthlessness 0.08 0.141 0.07 0.183 0.06 0.273 0.06 0.309
PHQ 7: Concentration problems 0.00 0.985 0.01 0.915 0.01 0.904 0.00 0.927
PHQ 8: Psychomotor changes 0.04 0.464 0.05 0.368 0.05 0.377 0.05 0.370
PHQ 9: Suicidal ideation 0.17 0.002 0.17 0.001 0.16 0.004 0.14 0.008
Model 1, unadjusted; Model 2, adjusted for sex, age; Model 3, adjusted for sex, age, education, ethnic minority; Model 4, adjusted for sex,
age, education, ethnic minority, insulin treatment, body mass index, smoking.
e120
ª 2012 The Authors.
Diabetic Medicine ª 2012 Diabetes UK
DIABETICMedicine Associations between depressive symptoms and glycaemic control  M. Bot et al.
some of its items were double-barrelled. For example, the
item ‘appetite problems’ in PHQ-9 describes both increased
and decreased appetite. Similarly, the item on sleeping
difficulties describes both insomnia and excessive sleeping.
Third, depressive symptoms were only assessed at baseline
and not at follow-up, which limits the results of longitudinal
analyses. Fourth, it remains possible that the selection of
patients with diabetes from tertiary diabetes clinics only, and
the low uptake of the postal questionnaire, have biased the
associations for diabetes patients in general. Finally, our
study had an explorative character, in particular the analyses
stratified for Type 1 and Type 2 diabetes, which limits more
definitive statements regarding the association between
depressive symptoms and HbA1c.
Patients with elevated HbA1c values are to be considered
an at-risk group for specific depressive symptoms and
therefore warrant special attention. HbA1c is a potential
clinical mediator of the relationship between depressive
symptoms and diabetes complications [30]. Future prospec-
tive studies should be conducted to confirm this proposed
mediation, taking into account the heterogeneous phenom-
enology of depression.
In summary, the heterogeneity of depression may help to
explain why some studies found relationships between
depression and HbA1c while others did not, as some
symptoms may link more strongly to HbA1c. We found that
depressed mood, sleeping difficulties, appetite problems and
suicidal ideation appear to be more strongly related to HbA1c
levels, in particular in individuals with Type 1 diabetes.
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Table 3 Standardized regression coefficients from nine separate linear regression analyses for the association of each Patient Health Questionnaire
(PHQ) item and follow-up HbA1c
Model 1 Model 2 Model 3 Model 4
b P b P b P b P
Total sample (n = 525)
PHQ 1: Lack of interest 0.02 0.595 0.02 0.656 0.02 0.710 0.02 0.721
PHQ 2: Depressed mood 0.11 0.013 0.10 0.021 0.10 0.026 0.09 0.031
PHQ 3: Sleeping difficulties 0.13 0.003 0.13 0.003 0.13 0.003 0.12 0.004
PHQ 4: Fatigue 0.09 0.039 0.07 0.100 0.07 0.099 0.06 0.136
PHQ 5: Appetite problems 0.12 0.004 0.11 0.009 0.11 0.008 0.11 0.011
PHQ 6: Worthlessness 0.07 0.112 0.06 0.152 0.06 0.181 0.06 0.150
PHQ 7: Concentration problems 0.06 0.139 0.07 0.099 0.07 0.094 0.08 0.066
PHQ 8: Psychomotor changes 0.08 0.069 0.09 0.043 0.09 0.039 0.09 0.038
PHQ 9: Suicidal ideation 0.08 0.085 0.08 0.065 0.08 0.081 0.07 0.100
Type 1 diabetes (n = 232)
PHQ 1: Lack of interest 0.15 0.022 0.13 0.039 0.13 0.041 0.12 0.053
PHQ 2: Depressed mood 0.13 0.043 0.12 0.064 0.12 0.065 0.12 0.056
PHQ 3: Sleeping difficulties 0.24 < 0.001 0.23 < 0.001 0.23 < 0.001 0.21 0.001
PHQ 4: Fatigue 0.13 0.046 0.10 0.144 0.10 0.142 0.08 0.217
PHQ 5: Appetite problems 0.20 0.002 0.19 0.003 0.20 0.003 0.17 0.010
PHQ 6: Worthlessness 0.07 0.294 0.06 0.350 0.06 0.336 0.05 0.428
PHQ 7: Concentration problems 0.18 0.005 0.18 0.004 0.18 0.004 0.19 0.003
PHQ 8: Psychomotor changes 0.12 0.061 0.12 0.066 0.12 0.059 0.13 0.038
PHQ 9: Suicidal ideation 0.04 0.536 0.03 0.649 0.03 0.626 0.03 0.605
Type 2 diabetes (n = 291)
PHQ 1: Lack of interest –0.06 0.287 –0.06 0.286 –0.07 0.242 –0.07 0.269
PHQ 2: Depressed mood 0.09 0.138 0.08 0.160 0.07 0.213 0.07 0.250
PHQ 3: Sleeping difficulties 0.05 0.354 0.05 0.358 0.05 0.376 0.05 0.361
PHQ 4: Fatigue 0.07 0.237 0.06 0.322 0.05 0.352 0.05 0.412
PHQ 5: Appetite problems 0.07 0.208 0.06 0.294 0.06 0.278 0.07 0.248
PHQ 6: Worthlessness 0.07 0.200 0.07 0.261 0.06 0.317 0.07 0.272
PHQ 7: Concentration problems 0.00 0.964 0.01 0.902 0.01 0.871 0.02 0.769
PHQ 8: Psychomotor changes 0.06 0.349 0.07 0.264 0.07 0.232 0.07 0.221
PHQ 9: Suicidal ideation 0.10 0.077 0.11 0.055 0.11 0.075 0.10 0.094
Model 1, unadjusted; Model 2: adjusted for sex, age; Model 3, adjusted for sex, age, education, ethnic minority; Model 4, adjusted for sex,
age, education, ethnic minority, insulin treatment, body mass index, smoking.
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